---
title: "ANGI GWAS"
id: "6542"
type: "sample_set"
slug: "snd10081"
published_at: "2024-03-15T14:22:48+00:00"
modified_at: "2024-03-15T14:22:49+00:00"
url: "https://dss.niagads.org/sample-sets/snd10081/"
markdown_url: "https://dss.niagads.org/sample-sets/snd10081.md"
excerpt: "The first release includes quality controlled GWAS data on 1,647 participants from the ANGI cohort. It also includes phenotypes provided by the ANGI Study."
---

## Description

The first release includes quality controlled GWAS data on 1,647 participants from the ANGI cohort. It also includes phenotypes provided by the ANGI Study.

## Cohorts

- [Amyloid Neuroimaging and Genetics Initiative (ANGI)](https://dss.niagads.org/cohorts/amyloid-neuroimaging-and-genetics-initiative-angi/)

## Sex

### Total number of samples: 1,647

Female72043.7 %

Male92756.3 %

## Race

### Total number of samples: 1,647

| American Indian/Alaska Native | 2 |
| --- | --- |
| Asian | 8 |
| Black or African American | 20 |
| White | 1,603 |
| Other | 12 |
| NA | 2 |

## Ethnicity

### Total number of samples: 1,647

Not Hispanic or Latino

1,612

97.9%

Hispanic or Latino

28

1.7%

Not Applicable/Not Available

7

0.4%

## Diagnosis

### Total number of samples: 1,647

| Dementia |  |  |
| --- | --- | --- |
| Case | 422 | 25.6% |

| Mild Cognitive Impairment (MCI) |  |  |
| --- | --- | --- |
| Case | 1,224 | 74.3% |

| NA |  |  |
| --- | --- | --- |
| Unknown | 1 | 0.1% |

## APOE

### Total number of samples: 1,647

- 224 (0.2%)
- 23103 (6.3%)
- 2445 (2.7%)
- 33703 (42.7%)
- 34633 (38.4%)
- 44157 (9.5%)
- NA2 (0.1%)